You are here
MDMA LAUDED AS ‘BREAKTHROUGH’ THERAPY FOR PTSD PATIENTS Medical 

MDMA LAUDED AS ‘BREAKTHROUGH’ THERAPY FOR PTSD PATIENTS

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Read the full article

Related posts